Cargando…

Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient

Detalles Bibliográficos
Autores principales:	Morales, Enrique, Morales, Rafael, Gutiérrez, Eduardo, Rojas-Rivera, Jorge, Praga, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Educational Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400569/ https://www.ncbi.nlm.nih.gov/pubmed/26069815 http://dx.doi.org/10.1093/ckj/sfs150

Ejemplares similares

Hereditary Hæmorrhagic Telangiectasia with Recurring Hæmaturia
por: Foggie, W. E.
Publicado: (1928)

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study
por: Delagrange, Laura, et al.
Publicado: (2022)

Peliosis hepatis associated with hereditary haemorrhagic telangiectasia
por: Alessandrino, F., et al.
Publicado: (2013)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Hereditary Haemorrhagic Telangiectasia: With Report of a Case
por: McEwan, Tom
Publicado: (1948)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Hereditary haemorrhagic telangiectasia: A case report
por: Mufti, Asfandyar, et al.
Publicado: (2021)

Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
por: Ou, George, et al.
Publicado: (2016)

Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia
por: Chavan, Ajay, et al.
Publicado: (2012)

A case report of successful treatment of high-output heart failure secondary to hereditary haemorrhagic telangiectasia with bevacizumab
por: Flower, Mark, et al.
Publicado: (2019)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature
por: Dupuis, Olivier, et al.
Publicado: (2020)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia
por: FIORELLA, M.L., et al.
Publicado: (2012)

Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia
por: Wrobeln, Anna, et al.
Publicado: (2022)

Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
por: Wee, Jee Wan, et al.
Publicado: (2014)

Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
por: Masood, Muaaz, et al.
Publicado: (2021)

Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report
por: Ospina, Fabio E, et al.
Publicado: (2017)

Neurologic Manifestation as Initial Presentation in a Case of Hereditary Haemorrhagic Telangiectasia
por: Teo, Yeow Kwan, et al.
Publicado: (2010)

Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience
por: Pagella, Fabio, et al.
Publicado: (2021)

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2021)

An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms
por: Arthur, Helen M., et al.
Publicado: (2022)

Endoglin is a conserved regulator of vasculogenesis in zebrafish – implications for hereditary haemorrhagic telangiectasia
por: Zhang, Ding, et al.
Publicado: (2019)

An update on the ophthalmic features in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
por: Abdolrahimzadeh, Solmaz, et al.
Publicado: (2022)

Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia
por: Snodgrass, Ryan O., et al.
Publicado: (2023)

The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function
por: Lyster, Anne Lørup, et al.
Publicado: (2023)

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
por: Thompson, Andrew B., et al.
Publicado: (2014)

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report
por: Maestraggi, Quentin, et al.
Publicado: (2015)

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report
por: Huemer, Florian, et al.
Publicado: (2016)

Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia
por: Ali, Bassam R., et al.
Publicado: (2011)

Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls
por: Hosman, Anna E, et al.
Publicado: (2013)

Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia
por: Shovlin, Claire L., et al.
Publicado: (2016)

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability
por: Revuz, Sabine, et al.
Publicado: (2017)

Life-threatening Anaemia in Patient with Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)
por: Mikołajczyk-Solińska, Melania, et al.
Publicado: (2020)

Correction: Endoglin is a conserved regulator of vasculogenesis in zebrafish - implications for hereditary haemorrhagic telangiectasia
Publicado: (2021)

Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia
por: Vázquez, Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_drl84iqb8pjs394osanhj9trp7